Literature DB >> 25770011

Revisiting the sphingolipid rheostat: Evolving concepts in cancer therapy.

Jason Newton1, Santiago Lima1, Michael Maceyka1, Sarah Spiegel2.   

Abstract

Entities:  

Keywords:  Ceramide; Sphingolipid rheostat; Sphingosine kinase; Sphingosine-1-phosphate

Mesh：

Substances：

Year:  2015        PMID： 25770011      PMCID： PMC4415605          DOI： 10.1016/j.yexcr.2015.02.025

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN： 0014-4827            Impact factor:   3.905


× No keyword cloud information.
  46 in total

Review 1.  Truth and consequences of sphingosine-1-phosphate lyase.

Authors:  Ana Aguilar; Julie D Saba
Journal:  Adv Biol Regul       Date:  2012-01

Review 2.  Sphingosine-1-phosphate and its receptors: structure, signaling, and influence.

Authors:  Hugh Rosen; Raymond C Stevens; Michael Hanson; Edward Roberts; Michael B A Oldstone
Journal:  Annu Rev Biochem       Date:  2013-03-18       Impact factor: 23.643

3.  Inhibition of sphingosine kinase 2 downregulates the expression of c-Myc and Mcl-1 and induces apoptosis in multiple myeloma.

Authors:  Jagadish Kummetha Venkata; Ningfei An; Robert Stuart; Luciano J Costa; Houjian Cai; Woodrow Coker; Jin H Song; Kiwana Gibbs; Terri Matson; Elizabeth Garrett-Mayer; Zhuang Wan; Besim Ogretmen; Charles Smith; Yubin Kang
Journal:  Blood       Date:  2014-09-18       Impact factor: 22.113

4.  Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.

Authors:  Masayuki Nagahashi; Subramaniam Ramachandran; Eugene Y Kim; Jeremy C Allegood; Omar M Rashid; Akimitsu Yamada; Renping Zhao; Sheldon Milstien; Huiping Zhou; Sarah Spiegel; Kazuaki Takabe
Journal:  Cancer Res       Date:  2012-02-01       Impact factor: 12.701

Review 5.  Sphingosine 1-phosphate and cancer.

Authors:  Nigel J Pyne; Susan Pyne
Journal:  Nat Rev Cancer       Date:  2010-06-17       Impact factor: 60.716

6.  Molecular basis of sphingosine kinase 1 substrate recognition and catalysis.

Authors:  Zhulun Wang; Xiaoshan Min; Shou-Hua Xiao; Sheree Johnstone; William Romanow; David Meininger; Haoda Xu; Jinsong Liu; Jessica Dai; Songzhu An; Stephen Thibault; Nigel Walker
Journal:  Structure       Date:  2013-04-18       Impact factor: 5.006

7.  Pharmacology and antitumor activity of ABC294640, a selective inhibitor of sphingosine kinase-2.

Authors:  Kevin J French; Yan Zhuang; Lynn W Maines; Peng Gao; Wenxue Wang; Vladimir Beljanski; John J Upson; Cecelia L Green; Staci N Keller; Charles D Smith
Journal:  J Pharmacol Exp Ther       Date:  2010-01-08       Impact factor: 4.030

Review 8.  Export of sphingosine-1-phosphate and cancer progression.

Authors:  Kazuaki Takabe; Sarah Spiegel
Journal:  J Lipid Res       Date:  2014-01-28       Impact factor: 5.922

9.  Antiapoptotic roles of ceramide-synthase-6-generated C16-ceramide via selective regulation of the ATF6/CHOP arm of ER-stress-response pathways.

Authors:  Can E Senkal; Suriyan Ponnusamy; Jacek Bielawski; Yusuf A Hannun; Besim Ogretmen
Journal:  FASEB J       Date:  2009-09-01       Impact factor: 5.191

10.  Sphingosine-1-phosphate, a novel lipid, involved in cellular proliferation.

Authors:  H Zhang; N N Desai; A Olivera; T Seki; G Brooker; S Spiegel
Journal:  J Cell Biol       Date:  1991-07       Impact factor: 10.539
View more
  88 in total

Review 1.  Clinical application of ceramide in cancer treatment.

Authors:  Kazuki Moro; Masayuki Nagahashi; Emmanuel Gabriel; Kazuaki Takabe; Toshifumi Wakai
Journal:  Breast Cancer       Date:  2019-04-08       Impact factor: 4.239

2.  Sphingosine kinase 1 participates in the activation, proliferation and survival of chronic lymphocytic leukemia cells.

Authors:  María Belén Almejún; Mercedes Borge; Ana Colado; Esteban Enrique Elías; Enrique Podaza; Denise Risnik; Carlos Daniel De Brasi; Carmen Stanganelli; Irma Slavutsky; María Cabrejo; Horacio Fernández-Grecco; Raimundo Fernando Bezares; Santiago Cranco; Rubén Ángel Burgos; Julio César Sánchez-Ávalos; Pablo Oppezzo; Mirta Giordano; Romina Gamberale
Journal:  Haematologica       Date:  2017-03-30       Impact factor: 9.941

3.  Upregulation of human glycolipid transfer protein (GLTP) induces necroptosis in colon carcinoma cells.

Authors:  Shrawan Kumar Mishra; Daniel J Stephenson; Charles E Chalfant; Rhoderick E Brown
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2018-11-22       Impact factor: 4.698

4.  A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.

Authors:  Carolyn D Britten; Elizabeth Garrett-Mayer; Steven H Chin; Keisuke Shirai; Besim Ogretmen; Tricia A Bentz; Alan Brisendine; Kate Anderton; Susan L Cusack; Lynn W Maines; Yan Zhuang; Charles D Smith; Melanie B Thomas
Journal:  Clin Cancer Res       Date:  2017-04-18       Impact factor: 12.531

5.  New fluorogenic probes for neutral and alkaline ceramidases.

Authors:  Mireia Casasampere; Núria Bielsa; Daniel Riba; Laura Bassas; Ruijuan Xu; Cungui Mao; Gemma Fabriàs; José-Luis Abad; Antonio Delgado; Josefina Casas
Journal:  J Lipid Res       Date:  2019-03-29       Impact factor: 5.922

Review 6.  Interdiction of Sphingolipid Metabolism Revisited: Focus on Prostate Cancer.

Authors:  Christina Voelkel-Johnson; James S Norris; Shai White-Gilbertson
Journal:  Adv Cancer Res       Date:  2018-06-20       Impact factor: 6.242

Review 7.  The emergence of acid ceramidase as a therapeutic target for acute myeloid leukemia.

Authors:  Su-Fern Tan; Jennifer M Pearson; David J Feith; Thomas P Loughran
Journal:  Expert Opin Ther Targets       Date:  2017-05-02       Impact factor: 6.902

8.  UDP-glucose ceramide glucosyltransferase activates AKT, promoted proliferation, and doxorubicin resistance in breast cancer cells.

Authors:  Marthe-Susanna Wegner; Nina Schömel; Lisa Gruber; Stephanie Beatrice Örtel; Matti Aleksi Kjellberg; Peter Mattjus; Jennifer Kurz; Sandra Trautmann; Bing Peng; Martin Wegner; Manuel Kaulich; Robert Ahrends; Gerd Geisslinger; Sabine Grösch
Journal:  Cell Mol Life Sci       Date:  2018-03-17       Impact factor: 9.261

Review 9.  Sphingolipids in spinal cord injury.

Authors:  Zachary B Jones; Yi Ren
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-08-05

Review 10.  Sphingolipid De Novo Biosynthesis: A Rheostat of Cardiovascular Homeostasis.

Authors:  Linda Sasset; Yi Zhang; Teresa M Dunn; Annarita Di Lorenzo
Journal:  Trends Endocrinol Metab       Date:  2016-08-22       Impact factor: 12.015
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.